Global Influenza Vaccine Market Research Report 2021
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Influenza Vaccine Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Influenza Vaccine Market Overview:
Global Influenza Vaccine Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Influenza Vaccine involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Influenza Vaccine Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Influenza Vaccine market in 2020.
Global Influenza Vaccine Market Segmentation
By Type, Influenza Vaccine market has been segmented into:
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Others
By Application, Influenza Vaccine market has been segmented into:
Children
Adults
Elderly
Pregnancy
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Influenza Vaccine market are:
GSK
Sinovac
Changsheng
CCBIO
Aleph Biomedical
Sanofi
Lanzhou Institute Of Biological Product
Siobp
Hualan Bio
Tianyuan Bio-Pharma
Vaxtec
Hissen
Abbott
Novartis
Tasly&Jenner
Tiantan
1. Market Overview of Influenza Vaccine
1.1 Influenza Vaccine Market Overview
1.1.1 Influenza Vaccine Product Scope
1.1.2 Market Status and Outlook
1.2 Influenza Vaccine Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Influenza Vaccine Historic Market Size by Regions (2015-2020)
1.4 Influenza Vaccine Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Influenza Vaccine Sales Market by Type (2015-2026)
2.1 Global Influenza Vaccine Historic Market Size by Type (2015-2020)
2.2 Global Influenza Vaccine Forecasted Market Size by Type (2021-2026)
2.3 Trivalent Influenza Vaccine
2.4 Quadrivalent Influenza Vaccine
2.5 Others
3. Covid-19 Impact Influenza Vaccine Sales Market by Application (2015-2026)
3.1 Global Influenza Vaccine Historic Market Size by Application (2015-2020)
3.2 Global Influenza Vaccine Forecasted Market Size by Application (2021-2026)
3.3 Children
3.4 Adults
3.5 Elderly
3.6 Pregnancy
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Influenza Vaccine Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Influenza Vaccine Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Influenza Vaccine Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Influenza Vaccine Business
5.1 GSK
5.1.1 GSK Company Profile
5.1.2 GSK Influenza Vaccine Product Specification
5.1.3 GSK Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Sinovac
5.2.1 Sinovac Company Profile
5.2.2 Sinovac Influenza Vaccine Product Specification
5.2.3 Sinovac Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Changsheng
5.3.1 Changsheng Company Profile
5.3.2 Changsheng Influenza Vaccine Product Specification
5.3.3 Changsheng Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 CCBIO
5.4.1 CCBIO Company Profile
5.4.2 CCBIO Influenza Vaccine Product Specification
5.4.3 CCBIO Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Aleph Biomedical
5.5.1 Aleph Biomedical Company Profile
5.5.2 Aleph Biomedical Influenza Vaccine Product Specification
5.5.3 Aleph Biomedical Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Sanofi
5.6.1 Sanofi Company Profile
5.6.2 Sanofi Influenza Vaccine Product Specification
5.6.3 Sanofi Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Lanzhou Institute Of Biological Product
5.7.1 Lanzhou Institute Of Biological Product Company Profile
5.7.2 Lanzhou Institute Of Biological Product Influenza Vaccine Product Specification
5.7.3 Lanzhou Institute Of Biological Product Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Siobp
5.8.1 Siobp Company Profile
5.8.2 Siobp Influenza Vaccine Product Specification
5.8.3 Siobp Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Hualan Bio
5.9.1 Hualan Bio Company Profile
5.9.2 Hualan Bio Influenza Vaccine Product Specification
5.9.3 Hualan Bio Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Tianyuan Bio-Pharma
5.10.1 Tianyuan Bio-Pharma Company Profile
5.10.2 Tianyuan Bio-Pharma Influenza Vaccine Product Specification
5.10.3 Tianyuan Bio-Pharma Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 Vaxtec
5.11.1 Vaxtec Company Profile
5.11.2 Vaxtec Influenza Vaccine Product Specification
5.11.3 Vaxtec Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 Hissen
5.12.1 Hissen Company Profile
5.12.2 Hissen Influenza Vaccine Product Specification
5.12.3 Hissen Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.13 Abbott
5.13.1 Abbott Company Profile
5.13.2 Abbott Influenza Vaccine Product Specification
5.13.3 Abbott Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.14 Novartis
5.14.1 Novartis Company Profile
5.14.2 Novartis Influenza Vaccine Product Specification
5.14.3 Novartis Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.15 Tasly&Jenner
5.15.1 Tasly&Jenner Company Profile
5.15.2 Tasly&Jenner Influenza Vaccine Product Specification
5.15.3 Tasly&Jenner Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.16 Tiantan
5.16.1 Tiantan Company Profile
5.16.2 Tiantan Influenza Vaccine Product Specification
5.16.3 Tiantan Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Influenza Vaccine Market Size (2015-2026)
6.2 North America Influenza Vaccine Key Players in North America (2015-2020)
6.3 North America Influenza Vaccine Market Size by Type (2015-2020)
6.4 North America Influenza Vaccine Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Influenza Vaccine Market Size (2015-2026)
7.2 East Asia Influenza Vaccine Key Players in North America (2015-2020)
7.3 East Asia Influenza Vaccine Market Size by Type (2015-2020)
7.4 East Asia Influenza Vaccine Market Size by Application (2015-2020)
8. Europe
8.1 Europe Influenza Vaccine Market Size (2015-2026)
8.2 Europe Influenza Vaccine Key Players in North America (2015-2020)
8.3 Europe Influenza Vaccine Market Size by Type (2015-2020)
8.4 Europe Influenza Vaccine Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Influenza Vaccine Market Size (2015-2026)
9.2 South Asia Influenza Vaccine Key Players in North America (2015-2020)
9.3 South Asia Influenza Vaccine Market Size by Type (2015-2020)
9.4 South Asia Influenza Vaccine Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Influenza Vaccine Market Size (2015-2026)
10.2 Southeast Asia Influenza Vaccine Key Players in North America (2015-2020)
10.3 Southeast Asia Influenza Vaccine Market Size by Type (2015-2020)
10.4 Southeast Asia Influenza Vaccine Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Influenza Vaccine Market Size (2015-2026)
11.2 Middle East Influenza Vaccine Key Players in North America (2015-2020)
11.3 Middle East Influenza Vaccine Market Size by Type (2015-2020)
11.4 Middle East Influenza Vaccine Market Size by Application (2015-2020)
12. Africa
12.1 Africa Influenza Vaccine Market Size (2015-2026)
12.2 Africa Influenza Vaccine Key Players in North America (2015-2020)
12.3 Africa Influenza Vaccine Market Size by Type (2015-2020)
12.4 Africa Influenza Vaccine Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Influenza Vaccine Market Size (2015-2026)
13.2 Oceania Influenza Vaccine Key Players in North America (2015-2020)
13.3 Oceania Influenza Vaccine Market Size by Type (2015-2020)
13.4 Oceania Influenza Vaccine Market Size by Application (2015-2020)
14. South America
14.1 South America Influenza Vaccine Market Size (2015-2026)
14.2 South America Influenza Vaccine Key Players in North America (2015-2020)
14.3 South America Influenza Vaccine Market Size by Type (2015-2020)
14.4 South America Influenza Vaccine Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Influenza Vaccine Market Size (2015-2026)
15.2 Rest of the World Influenza Vaccine Key Players in North America (2015-2020)
15.3 Rest of the World Influenza Vaccine Market Size by Type (2015-2020)
15.4 Rest of the World Influenza Vaccine Market Size by Application (2015-2020)
16 Influenza Vaccine Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Influenza Vaccine Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|